Bedrocan Cannabis (FRA:8BC) EV-to-EBIT : -30.38 (As of May. 22, 2024)

Bedrocan Cannabis EV-to-EBIT Chart

Bedrocan Cannabis Quarterly Data
	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15
EV-to-EBIT	Get a 7-Day Free Trial					-7.45	-	-61.45	-86.46	-32.36

Competitive Comparison of Bedrocan Cannabis's EV-to-EBIT

For the Biotechnology subindustry, Bedrocan Cannabis's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bedrocan Cannabis's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bedrocan Cannabis's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bedrocan Cannabis's EV-to-EBIT falls into.

Bedrocan Cannabis EV-to-EBIT Calculation

Bedrocan Cannabis's EV-to-EBIT for today is calculated as:

Bedrocan Cannabis's current Enterprise Value is €35.52 Mil.
Bedrocan Cannabis's EBIT for the trailing twelve months (TTM) ended in Apr. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bedrocan Cannabis  (FRA:8BC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Bedrocan Cannabis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2015 is calculated as:

Bedrocan Cannabis's Enterprise Value for the quarter that ended in Apr. 2015 was €0.00 Mil.
Bedrocan Cannabis's EBIT for the trailing twelve months (TTM) ended in Apr. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bedrocan Cannabis EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Bedrocan Cannabis's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Bedrocan Cannabis (FRA:8BC) Business Description